Calam, Ashly Khate P.
HRN: 20-87-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
09/11/2023
09/18/2023
ORAL
3ml
Q6hrs
Cellulitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes